[1]
C. M. Manjula and J. P. Majra, “Adverse drug reactions among new sputum positive pulmonary tuberculosis patients on daily treatment regimen: a prospective study from Haryana, India”, Int J Community Med Public Health, vol. 8, no. 2, pp. 775–780, Jan. 2021.